FBLG

FibroBiologics, Inc.

Healthcare · Biotechnology

$171.18 sample

+0.78 (+0.46%) 1D

Market cap

$731.0B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-24

Alerts

8

Price$171.18 +0.44% 3M daily closessample

176.94160.66

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24SECForm 144 filed
Sep 21SECForm 144 filed
Sep 14INSInsider buy: General Counsel
Sep 09INSInsider sell: Director
Aug 31SEC10-Q filed
Aug 21INSInsider buy: Director
Aug 13INSInsider buy: EVP, Operations
Aug 07INSInsider sell: Chief Financial Officer

Sign up to see the real FBLG record →

Company facts

SEC EDGAR registration

Name: FibroBiologics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -33sample, -100 to +100
Reporting currency: USD

Who is positioning in FBLG

sample

Insiders: 10 insider transactions over 90 days, net selling, $90.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 7 funds hold $16.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$26.6B +18.2% y/y

Q4 2024Q3 2026

Inventory$14.8B +9.2% y/y

Q4 2024Q3 2026

Accounts receivable$11.2B +10.9% y/y

Q4 2024Q3 2026

Total debt$30.6B +8.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $301.6B +5.2% 3M
Sample peer B: $294.5B +12.5% 3M
Sample peer C: $537.0B -1.8% 3M
Sample peer D: $348.7B -11.9% 3M
Sample peer E: $582.7B +6.5% 3M